FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
|
Comparision between Aelea Commodities IPO and Nephro Care India IPO.
Aelea Commodities IPO is a SME Book Built Issue IPO proposed to list at BSE SME while Nephro Care India IPO is a SME Book Built Issue proposed to list at NSE SME.
Aelea Commodities IPO | Nephro Care India IPO | |
---|---|---|
Logo | ![]() |
![]() |
Issue Category | SME | SME |
Issue Type | IPO | IPO |
Process Type | Book Built Issue | Book Built Issue |
Listing At | BSE SME | NSE SME |
Lead Managers | Ekadrisht Capital Private Limited | Corporate Capitalventures Pvt Ltd |
Registrar | Maashitla Securities Private Limited | Bigshare Services Pvt Ltd |
Market Maker | Ss Corporate Securities Limited | |
DRHP | DRHP ![]() |
DRHP ![]() |
RHP | RHP ![]() |
|
Anchor Investor | Anchor Investor ![]() |
|
IPO Allotment URL |
The total issue size of Aelea Commodities IPO is whereas the issue size of the Nephro Care India IPO is up to ₹41.26 Cr. The final issue price of Aelea Commodities IPO is and of Nephro Care India IPO is ₹90.00 per share.
Aelea Commodities IPO | Nephro Care India IPO | |
---|---|---|
Face Value | ₹10 per share | ₹10 per share |
Issue Price (Lower) | ₹85.00 per share | |
Issue Price (Upper) | ₹90.00 per share | |
Issue Price (Final) | ₹90.00 per share | |
Discount (Retail) | ||
Discount (Employee) | ||
Market Lot Size | 1600 shares | |
Fresh Issue Size | 55,00,000 shares | 45,84,000 shares |
Fresh Issue Size (Amount) | up to ₹41.26 Cr | |
OFS Issue Size | ||
OFS Issue Size (Amount) | ||
Issue Size Total | 55,00,000 shares | 45,84,000 shares |
Issue Size Total (Amount) | up to ₹41.26 Cr |
Aelea Commodities IPO opens on , while Nephro Care India IPO opens on Jun 28, 2024. The closing date of Aelea Commodities IPO and Nephro Care India IPO is , and Jul 02, 2024, respectively.
Aelea Commodities IPO | Nephro Care India IPO | |
---|---|---|
Anchor Bid Date | Jun 27, 2024 | |
Issue Open | Jun 28, 2024 | |
Issue Close | Jul 02, 2024 | |
Basis Of Allotment (Tentative) | Jul 03, 2024 | |
Initiation of Refunds (Tentative) | Jul 04, 2024 | |
Credit of Share (Tentative) | Jul 04, 2024 | |
Listing date (Tentative) | Jul 05, 2024 | |
Anchor Lockin End date 1 | Aug 02, 2024 | |
Anchor Lockin End date 2 | Oct 01, 2024 |
Aelea Commodities IPO P/E ratio is , as compared to Nephro Care India IPO P/E ratio of 55.15.
Aelea Commodities IPO | Nephro Care India IPO | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Financial | Aelea Commodities Limited Financial Information (Restated Consolidated)Aelea Commodities Limited's revenue increased by 4.39% and profit after tax (PAT) dropped by -82.01% between the financial year ending with March 31, 2023 and March 31, 2022.
|
Nephro Care India Limited Financial Information (Restated)Nephro Care India Limited's revenue increased by 398.84% and profit after tax (PAT) rose by 19920.41% between the financial year ending with March 31, 2023 and March 31, 2022.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Promoter Shareholding (Pre-Issue) | 86.45% | 85.02% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Promoter Shareholding (Post-Issue) | 61.39% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
P/E Ratio | 55.15 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Market Cap | ₹148.38 Cr. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ROE | 41.57%% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ROCE | 36.56%% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt/Equity | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
EPS | ₹1.63 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
RoNW | 24.42%% |
In the Aelea Commodities IPO retail investors (RII) are offered while in Nephro Care India IPO retail investors are offered . Qualified institutional buyers (QIB) are offered in Aelea Commodities IPO and 8,25,600 shares in Nephro Care India IPO.
Aelea Commodities IPO | Nephro Care India IPO | |
---|---|---|
Anchor Investor Reserveration | 12,38,400 shares | |
Market Maker Reserveration | 2,30,400 shares | |
QIB | 8,25,600 shares | |
NII | 6,19,200 shares | |
RII | 14,44,800 shares | |
Employee | 0 shares | |
Others | ||
Total | 31,15,200 shares |
Aelea Commodities IPO subscribed in total, whereas Nephro Care India IPO subscribed 715.78x.
Aelea Commodities IPO | Nephro Care India IPO | |
---|---|---|
QIB (times) | 245.14x | |
NII (times) | 1,787.19x | |
Big NII (times) | ||
Small NII (times) | ||
RII (times) | 634.12x | |
Employee (times) | ||
Other (times) | ||
Total (times) | 715.78x |
Add a public comment...
FREE Intraday Trading (Eq, F&O)
Flat ₹20 Per Trade in F&O
|